Ignite Creation Date:
2024-05-06 @ 1:20 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01781702
Status:
COMPLETED
Last Update Posted:
2013-08-09
First Post:
2013-01-30
Brief Title:
Phase 3 Study of Pelubiprofen Tab Celebrex Cap in Rheumatoid Arthritis Patients
Sponsor:
Daewon Pharmaceutical Co Ltd
Organization:
Daewon Pharmaceutical Co Ltd
Organization Data
Organization:
Daewon Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
DW Plb RA301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daewon Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None